They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

WASHINGTON -- So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...